Presenting on Emerging Growth Conference 88 Day 2 on December 11; Register to live stream
Globe Newswire (Wed, 10-Dec 7:00 AM ET)
Presenting on Emerging Growth Conference 88 Day 1 on December 10; Register to live stream
Globe Newswire (Tue, 9-Dec 7:00 AM ET)
PRNewswire (Tue, 2-Dec 9:54 AM ET)
OSR Holdings to Present at the Emerging Growth Conference on December 10, 2025
PRNewswire (Mon, 1-Dec 3:02 PM ET)
Market Chameleon (Mon, 24-Nov 5:31 AM ET)
Market Chameleon (Fri, 21-Nov 4:52 AM ET)
PRNewswire (Fri, 21-Nov 9:20 AM ET)
PRNewswire (Fri, 14-Nov 11:11 AM ET)
PRNewswire (Thu, 6-Nov 8:30 AM ET)
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.
Osr Holdings trades on the NASDAQ stock market under the symbol OSRH.
As of December 18, 2025, OSRH stock price climbed to $0.57 with 346,015 million shares trading.
OSRH has a beta of 1.90, meaning it tends to be more sensitive to market movements. OSRH has a correlation of 0.07 to the broad based SPY ETF.
OSRH has a market cap of $14.71 million. This is considered a Sub-Micro Cap stock.
The top ETF exchange traded funds that OSRH belongs to (by Net Assets): VXF.
OSRH support price is $.48 and resistance is $.61 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that OSRH shares will trade within this expected range on the day.
